logo
  1. Home
  2. Stocks
  3. Bal Pharma

Bal Pharma Share Price

Small Cap | Pharmaceuticals and health care | NSE: BALPHARMA | BSE: 524824

₹110.84 image-11.39 (-9.32 %)

Last Updated: 07 Apr 2025 11:44 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 118.01

High (₹) 118.01

Low (₹) 110.00

Prev. Close (₹) 122.23

Volume 1,89,845

VWAP (₹) 87.93

ROCE (%) 20.86

Industry P/E 44.73

TTM P/E 24.31

P/B Ratio 2.53

Market Cap (₹) Cr.176.47

Dividend Yield (%)1.08

EPS (₹) 4.96

ROE11.32%

Sales Growth (%) 11.51

Profit Growth (%)184.27

Day Range

118.01118.01

L
H

52 Week Range

76.30157.90

L
H

Historical Returns

Returns (6M)

-17.87 %

Returns (1Y)

6.73 %

Returns (3Y)

-6.35 %

Returns (5Y)

165.8 %

Returns (6M)

-17.87 %

Returns (1Y)

6.73 %

Returns (3Y)

-6.35 %

Returns (5Y)

165.8 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (195.24%) TTM EPS Growth
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 195.24% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Strong short-term momentum: Price above short-term moving averages (EMA_10)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.
  • Price above EMA and SMA (50) indicates bullish momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bearish
Bullish

RSI 42.68

MFI 17.35

ATR 6.43

Commodity Channel Index -120.46

ROC125 -42.21

ROC21 -17.13

Williams %R -92.94

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current91.3794.5697.1488.7985.6083.0279.83
Week Ago98.6599.83101.7196.7795.5993.7192.53
Month Ago110.26115.44119.07106.63101.4597.8292.64

EMA & SMA
info_icon

110.84

Current Price

EMA & SMApin

Bullish Moving Averages

14

Bearish Moving Averages

6

5 Day 95.23

9 Day 93.91

10 Day 94.85

12 Day 96.54

14 Day 97.60

20 Day 102.02

26 Day 103.64

50 Day 111.62

100 Day 118.69

200 Day 119.68

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
PARTH INFIN BROKERS PVT LTDbulkSell04 Apr, 2025₹124.361,10,803NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell04 Apr, 2025₹121.171,32,023NSE
MUDUPULAVEMULA SURENDRANADHA REDDYbulkSell04 Apr, 2025₹121.511,23,412NSE
PARTH INFIN BROKERS PVT LTDbulkBuy04 Apr, 2025₹125.311,10,803NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy04 Apr, 2025₹121.031,32,023NSE
MUDUPULAVEMULA SURENDRANADHA REDDYbulkBuy04 Apr, 2025₹120.961,23,412NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell23 Aug, 2024₹143.0786,838NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy23 Aug, 2024₹142.8586,838NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkSell22 Aug, 2024₹134.9390,349NSE
NK SECURITIES RESEARCH PRIVATE LIMITEDbulkBuy22 Aug, 2024₹134.7490,349NSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
13 Apr, 2022SHAILESH SIROYAAcquisition₹50.007,50,000NSE
21 Dec, 2021MICRO LABS LIMITED RevisedAcquisition₹92.963,00,900NSE
21 Dec, 2021MICRO LABS LIMITED RevisedAcquisition₹92.963,00,900NSE
24 Nov, 2021MICRO LABS LIMITEDAcquisition₹92.454,00,000NSE
27 Aug, 2021MICRO LABS LIMITEDAcquisition₹0.003,00,900NSE
22 Mar, 2021SHAILESH SIROYAAcquisition₹50.006,50,000NSE
30 Mar, 2020SHAILESH SIORYAAcquisition₹NSE
30 Mar, 2020Anita SiroyaAcquisition₹NSE
30 Mar, 2020Micro Labs LimitedAcquisition₹NSE
30 Mar, 2020DILIP SURANAHUFAcquisition₹NSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
28 May, 2024Rs.1.2000 per share(12%)Final Dividend18 Sept, 202401 Jan, 1970
29 May, 2023Rs.1.0000 per share(10%)Final Dividend18 Sept, 202301 Jan, 1970
30 May, 2022Rs.1.0000 per share(10%)Final Dividend13 Sept, 202201 Jan, 1970

Announcements

DateSourceDetail
04 Apr, 2025NSE IndiaBal Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
04 Apr, 2025BSE IndiaWe are submitting the certificate in compliance with Regulation 74(5) of SEBI(DP) Regulations, for the quarter ended 31.03.2025.
28 Mar, 2025NSE IndiaBal Pharma Limited has informed the Exchange about NCLT order on Scheme of Arrangement/merger of Golden Drugs Pvt Ltd ( Transferer Company ) with Bal Pharma Ltd ( Transferee Company.)
28 Mar, 2025BSE IndiaHon''ble NCLT , Bangalore bench has approved the scheme of arrangement between Golden Drugs Pvt Ltd ( Transferer Company), a wholly owned subsidiary of the Company with Bal Pharma Ltd ( Transferee Company ) vide its order dated 26.03.2025.
25 Mar, 2025NSE IndiaBAL PHARMA LIMITED has informed the Exchange about Closure of Trading Window
25 Mar, 2025NSE IndiaBal Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
20 Mar, 2025BSE IndiaWithdrawal of reclassification application made with the exchanges, as per the provisions of Regulation 31A of SEBI(LODR) Regulations,2015.
20 Mar, 2025NSE IndiaBal Pharma Limited has informed the Exchange about withdrawal of its application for reclassification of promoters.
24 Feb, 2025NSE IndiaBal Pharma Limited has informed the Exchange regarding ''Update''s on Unaudited Financial Results-31.12.2024.
17 Feb, 2025NSE IndiaBal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited financial results for the quarter ended 31.12.2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & Fund Raising--27 Jan, 202513 Feb, 2025
Quarterly Results--06 Nov, 202414 Nov, 2024
Quarterly Results, ESOP & A.G.M.--29 Jul, 202412 Aug, 2024
Audited Results & Final Dividend--02 May, 202428 May, 2024
Quarterly Results--30 Jan, 202412 Feb, 2024
Quarterly Results & ESOP--23 Oct, 202308 Nov, 2023
Quarterly Results & A.G.M.--03 Aug, 202311 Aug, 2023
Audited Results & Final Dividend--17 May, 202329 May, 2023
Quarterly Results--30 Jan, 202306 Feb, 2023
Quarterly Results & ESOPInter alia, To convene Extra Ordinary General Meeting ( EGM ) for merger of Golden Drugs Pvt Ltd. a wholly owned subsidiary of the Company.07 Nov, 202214 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Dec, 2023Dec, 2022Dec, 2021Dec, 2020
Promoter Group50.86%51.23%51.61%49.57%42.45%
Foreign Institutions +0.14%0.13%0.18%0.31%0%
Domestic Institutions +0%0%0%0%0%
Government0%0%0%0%0%
Public49%48.64%48.21%50.12%57.55%
Others0%0%0%0%0%

About Bal Pharma

Bal Pharma is a Public Limited Listed company incorporated on 19/05/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008368 and registration number is 008368. Currently company belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 338.54 Cr. and Equity Capital is Rs. 15.80 Cr. for the Year ended 31/03/2024.

Parent Organisation

Micro Lab Group

Founded

1987

Managing Director

Mr. Shailesh D Siroya

NSE Symbol

BALPHARMA

Bal Pharma Management

NameDesignation
Mr. Shailesh D SiroyaManaging Director
Mr. Himesh VirupakshayaExecutive Director
Mr. Jatish ShethIndependent Director
Dr. C V SrinivasIndependent Director
Ms. Nicloa NeeladriIndependent Director
Mr. H S VenkateshIndependent Director
Mr. Kotian Chittananda DamodarExecutive Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,10,130.32₹1,654.80 image
₹1,709.35(-3.19%)		₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,45,552.44₹5,254.85 image
₹5,482.85(-4.16%)		₹3,640.100 - ₹6,448.750
Cipla₹1,14,298.01₹1,387.00 image
₹1,415.25(-2.00%)		₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,11,230.09₹3,275.10 image
₹3,286.50(-0.35%)		₹2,508.650 - ₹3,589.950
Mankind Pharma₹1,01,131.25₹2,432.65 image
₹2,451.20(-0.76%)		₹1,910.100 - ₹3,050.000

FAQs on Bal Pharma

What is the share price of Bal Pharma?

The share price of Bal Pharma on 07 Apr, 2025 is ₹ 110.84.

What is 52W high and 52W low share price of Bal Pharma?

The highest and lowest 52W share prices of Bal Pharma are ₹ 157.900 and ₹ 76.300

What is the market cap of Bal Pharma?

The market capitalization of Bal Pharma as of 07 Apr, 2025 is ₹ 176.47 Crores

What is the P/E ratio of Bal Pharma?

The current P/E ratio of Bal Pharma as of 07 Apr, 2025 is 44.73

What is the PB ratio of Bal Pharma?

The PB ratio of Bal Pharma as of 07 Apr, 2025 is 2.53

Top Gainers

GLOBUSCON

Globus Power Generation

₹18.07image

₹15.14 (0.19%)

SHANTIDENM

Shanti Spintex

₹66.60image

₹57.80 (0.15%)

DEL

Dhanashree Electronics

₹88.74image

₹73.95 (0.20%)

PARSHVA

Parshva Enterprises

₹197.50image

₹167.35 (0.18%)

Top Losers

GOLDIAM

Goldiam International

₹307.35image

₹368.55 (-0.17%)

EVERFIN

Everlon Financials

₹108.20image

₹127.00 (-0.15%)

KBCGLOBAL

KBC Global

₹0.54image

₹1.03 (-0.48%)

GRWRHITECH

Garware Hi-Tech Films

₹2,705.55image

₹3,206.90 (-0.16%)

Market Indices

Sensex

₹75,364.69image

₹76,295.36 (-0.01%)

Source : Dion Global Solutions Limited